Results 151 to 160 of about 790,552 (265)

Complete versus culprit only revascularization in ST-elevation myocardial infarction—a perspective on recent trials and recommendations [PDF]

, 2017
Gabriela Andries, Sahil Khera, Robert Timmermans, Wilbert S. Aronow   +3 more
openalex   +1 more source

Myocardial Revascularization in COVID-19 Era

, 2021
Sasmojo Widito
openalex   +1 more source

Retatrutide for the treatment of obesity, obstructive sleep apnea and knee osteoarthritis: Rationale and design of the TRIUMPH registrational clinical trials

Diabetes, Obesity and Metabolism, EarlyView.
Abstract Aims Retatrutide, a novel synthetic molecule, is a triple agonist activating the glucose‐dependent insulinotropic polypeptide, glucagon‐like peptide‐1 and glucagon receptors. The TRIUMPH clinical development program evaluates its safety and efficacy concurrently for the treatment of obesity and two related complications—obstructive sleep apnea
Kathryn Giblin, Lee M. Kaplan, Virend K. Somers, Carel W. Le Roux, David J. Hunter, Qiwei Wu, Amy Lalonde, Nadia Ahmad, Mary Angelyn Bethel   +8 more
wiley   +1 more source

The accuracy of the Stroke Risk Analysis (SRA) system for predicting atrial fibrillation in patients in the postoperative period of myocardial revascularization. [PDF]

PLoS One, 2023
Serafim KR, Moreira DAR, da Costa PA, Habib RG, Reyes CAS, Fragata CDS.   +5 more
europepmc   +1 more source

'Ten commandments' for the 2018 ESC/EACTS Guidelines on Myocardial Revascularization.

European Heart Journal, 2019
F. Neumann, M. Sousa‐Uva
semanticscholar   +1 more source

Improving cardiovascular risk stratification through the derivation and validation of an elevated triglyceride‐glucose index

Diabetes, Obesity and Metabolism, EarlyView.
Abstract Background and Aims Triglyceride‐glucose (TyG) index, is an emerging prognostic biomarker in atherosclerotic cardiovascular disease (ASCVD). Validation of its clinical value and of clinically relevant prognostic cut‐off, remains an unmet need to integrate TyG into primary prevention protocols.
Georgios Mavraganis, Georgios Georgiopoulos, Stavros Athanasopoulos, Dimitrios Terentes‐Printzios, Georgios Zervas, Christina Konstantaki, Maria Eleni Koilakou, Sofia‐Panagiota Giannakopoulou, Maria‐Angeliki Dimopoulou, Christina Chrysochoou, Konstantinos Tsioufis, Christos Pitsavos, Evangelos Liberopoulos, Konstantinos Stellos, Charalambos Vlachopoulos, Demosthenes Panagiotakos, Kimon Stamatelopoulos   +16 more
wiley   +1 more source

SCAI Expert Consensus Statement on Sex-Specific Considerations in Myocardial Revascularization. [PDF]

J Soc Cardiovasc Angiogr Interv, 2022
Lansky A, Baron SJ, Grines CL, Tremmel JA, Al-Lamee R, Angiolillo DJ, Chieffo A, Croce K, Jacobs AK, Madan M, Maehara A, Mehilli J, Mehran R, Ng V, Parikh PB, Saw J, Abbott JD.   +16 more
europepmc   +1 more source

Transmyocardial laser revascularization fails to prevent left ventricular functional deterioration and aneurysm formation after acute myocardial infarction in sheep [PDF]

, 1998
Ramin Malekan, Scott T. Kelley, Yasuyuki Suzuki, C Reynolds, Theodore Plappert, Martin St. John Sutton, L. Henry Edmunds, Charles R. Bridges   +7 more
openalex   +1 more source

Mental stress as a trigger of cardiovascular events: A narrative review

European Journal of Clinical Investigation, EarlyView.
Stress stimulates the prefrontal cortex that in turns activates the limbic system with subsequent activation of the autonomic nervous system. The autonomic nervous system then stimulates the heart, vessels, endocrine and immune systems with a bidirectional communication. These mechanisms increase heart rate and blood pressure, promote vasoconstriction,
Paolo Raggi
wiley   +1 more source

An Individualized Approach of Multidisciplinary Heart Team for Myocardial Revascularization and Valvular Heart Disease-State of Art. [PDF]

J Pers Med, 2022
Jonik S, Marchel M, Huczek Z, Kochman J, Wilimski R, Kuśmierczyk M, Grabowski M, Opolski G, Mazurek T.   +8 more
europepmc   +1 more source